Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 23.3.2021B.Braun Melsungen AG (BME)1340CNutriflex Omega plus 38/120 (emu inf 5x1250 ml (vak infúzny viackomorový))23.3.2021R
 23.3.2021B.Braun Melsungen AG (BME)1342CNutriflex Omega plus 38/120 (emu inf 5x2500 ml (vak infúzny viackomorový))23.3.2021R
 23.3.2021Ewopharma International, s.r.o. (EWO-SK-2)3272DISOPRINOSINE 1000 mg granulát na perorálny roztok vo vrecku (gro sac 24x1000 mg (vre.Pap50/Colle/ALU 9/Coex PE))23.3.2021O
 23.3.2021B.Braun Melsungen AG (BME)1344CNutriflex Omega special 56/144 (emu inf 5x1250 ml (vak infúzny viackomorový))23.3.2021R
 23.3.2021KRKA, d.d., Novo mesto (KRK-2)4404DXerdoxo 20 mg filmom obalené tablety (tbl flm 28x20 mg (blis.PVC/PVDC/PVC/Al-kalendár.bal.))23.3.2021R
 23.3.2021KRKA, d.d., Novo mesto (KRK-2)4407DXerdoxo 20 mg filmom obalené tablety (tbl flm 98x20 mg (blis.PVC/PVDC/PVC/Al-kalendár.bal.))23.3.2021R
 23.3.2021KRKA, d.d., Novo mesto (KRK-2)4420DXerdoxo 15 mg filmom obalené tablety (tbl flm 28x15 mg (blis.PVC/PVDC/PVC/Al-kalendár.bal.))23.3.2021R
 23.3.2021KRKA, d.d., Novo mesto (KRK-2)4421DXerdoxo 15 mg filmom obalené tablety (tbl flm 42x15 mg (blis.PVC/PVDC/PVC/Al-kalendár.bal.))23.3.2021R
 23.3.2021KRKA, d.d., Novo mesto (KRK-2)4423DXerdoxo 15 mg filmom obalené tablety (tbl flm 98x15 mg (blis.PVC/PVDC/PVC/Al-kalendár.bal.))23.3.2021R
 22.3.2021Pfizer Europe MA EEIG (PFI-BE-3)09710SOLU-MEDROL 125 mg (plv iol 1x125 mg+2 ml solv. (1x dvojkomorová Act-O-Vial))24.3.2021R
 22.3.2021Pfizer Europe MA EEIG (PFI-BE-3)91643PREPIDIL (gel vag 1x3 g/0,5 mg (striek.inj.napl.LDPE))29.3.2021R
 22.3.2021Bayer, spol. s r.o. (BAY-SK-2)31895Iberogast (sol por 1x100 ml (fľ.skl.hnedá))22.3.2021R
 22.3.2021Bayer, spol. s r.o. (BAY-SK-2)33061Aspirin 500 mg (tbl 20x500 mg (blis.PP/Al))22.3.2021R
 22.3.2021B.Braun Melsungen AG (BME)1345CNutriflex Omega special 56/144 (emu inf 5x1875 ml (vak infúzny viackomorový))22.3.2021R
 22.3.2021Mylan IRE Healthcare Limited (MYR)62402Fraxiparine 7 600 IU (anti Xa)/0,8 ml (sol inj 10x0,8 ml/7,6 KU (striek.inj.skl.napl.))23.3.2021R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)